Peregrine Pharmaceuticals, Inc. (PPHM) Misses Q2 Loss Views; Revs Stronger

December 12, 2011 4:09 PM EST
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) reported Q2 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $4.23 million versus the consensus estimate of $2.08 million.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Add Your Comment